Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Blood fat lowering capsules

A blood lipid-lowering capsule technology, applied in the field of biomedicine, can solve the problems of low absorption rate, offsetting curative effect, and inability to have the best of both worlds, and achieve the effect of rich nutrition, comprehensive nutrition, and avoiding side effects and insufficiencies

Inactive Publication Date: 2015-08-05
SHANGHAI TIANLONG BIOTECH CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0010] ④. There is dependence, long-term use will increase the risk of bleeding in patients, and it cannot regulate blood pressure in both directions, so it is not suitable for patients with hypotension
[0011] ⑤. There is no cure, and it will relapse immediately after stopping the drug
[0013] ①.Severe side effects, such as pantothenic acid, stomach discomfort, laxative, etc. People with hyperacidity or ulcer disease should use it with caution
[0014] ②. Can cause liver function damage, some drugs can increase blood sugar
[0015] ③. It can only be controlled within the normal range and cannot be completely cured
[0017] ①. It comes from animal fat and is rich in cholesterol. Long-term intake will increase the cholesterol in the human body and increase the risk of coronary heart disease;
Because it directly contains EPA and DHA and does not need to be transformed by the human body, the human body is passively absorbed, but the amount of EPA and DHA required by each person is different, and it is difficult to grasp and judge the required definite amount. When directly supplementing EPA and DHA for a long time , will interfere with the inherent metabolism of the human body;
[0020] ④. Easy to oxidize, fishy smell, bad taste;
[0021] ⑤. Low absorption rate
[0022] ⑥. Non-sustainable resources
[0024] ⑦. Heavy metal pollution is relatively serious, especially mercury pollution. Many deep-sea fish such as swordfish and tuna are likely to contain methylmercury
But there are still many problems: 1. The cost is high, generally tens of thousands of yuan per time; 2. The risk is high, and the safety of blood plasma transfusion is at risk; 3. The duration is short, usually lasting 3 to 10 months; 4. The symptoms are not cured. Treat the root cause, can not fundamentally solve the cardiovascular and cerebrovascular problems, last for 3 to 10 months and then rebound
Only lowering blood lipids without lowering blood pressure, the blood will rush around like a flood without resistance, which can easily cause cerebral hemorrhage and coronary heart disease. Efficacy, and many side effects
The current drug treatment only treats the symptoms but not the root cause, and does not solve the problem from the source. Therefore, there is no radical cure for hypertension in the prior art, and it will recur immediately after stopping the drug; and hyperlipidemia can only be controlled within the normal range, and cannot be completely cured.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0045] Example 1, a lipid-lowering capsule of the present invention contains 319.5 mg of α-linolenic acid, 73 mg of linoleic acid and 78 mg of oleic acid; the α-linolenic acid, linoleic acid and oleic acid are all derived from perilla oil. The capsule can also contain palmitic acid, stearic acid, Vc, Ve, β-carotene, diterpene, furanuronic acid, anthocyanin, calcium, iron, potassium, etc.

[0046] Capsule of the present invention has the following advantages:

[0047] The present invention is refined from perilla oil as the main raw material, which can be automatically metabolized in the human body through the conversion of various enzymes to generate: EPA, DPA, DHA and other active substances beneficial to the human body.

[0048] ①. The mechanism of lowering blood pressure of the product of the present invention is mainly realized by affecting the production of prostaglandins, and its metabolites can dilate blood vessels, enhance blood vessel elasticity, and reduce neutral fa...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention discloses blood fat lowering capsules, which contain alpha-linolenic acid, linoleic acid and oleic acid, wherein a mass ratio of the alpha-linolenic acid to the linoleic acid is 4.377+ / -0.1, and a mass ratio of the alpha-linolenic acid to the oleic acid is 4.096+ / -0.1. According to the present invention, the perilla frutescens oil is adopted as the main raw material, the blood fat lowering capsules are rich in a variety of nutrients beneficial to human body, the main ingredient such that the alpha-linolenic acid is the precursor of the omega-3 based essential fatty acid, the natural content is up to more than or equal to 62.5%, the ratio of the alpha-linolenic acid content to the linoleic acid content is up to more than or equal to 4:1, the blood fat lowering capsules are scientific and rational, the nutrition is comprehensive, a variety of side effects and disadvantages of the drugs can be effectively avoided, the low density lipoprotein content in the blood can be reduced, brain and heart can be effectively protected, and the blood fat lowering pathway through the prostaglandin provides the comprehensive blood fat lowering effect.

Description

technical field [0001] The invention belongs to the technical field of biomedicine, and in particular relates to a blood fat-reducing capsule. Background technique [0002] According to the National Society of Cardiovascular and Cerebrovascular Diseases in 2000, there are currently more than 180 million people with cardiovascular and cerebrovascular diseases in my country, and the average age of the patients has shifted from over 50 years old to 30-40 years old. The prevalence rate, morbidity rate, disability rate, and mortality rate are constantly increasing, and more than 3 million people die of cardiovascular and cerebrovascular diseases every year. Cardiovascular and cerebrovascular diseases have become the "first killer" of human health, accounting for more than 50% of the total mortality rate, with an average of 1 death every 10 seconds. An important cause of cardiovascular and cerebrovascular diseases is hyperlipidemia. [0003] A large number of research data show ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/202A61P3/06A61P9/12A61K31/201A61K36/535
Inventor 何颖
Owner SHANGHAI TIANLONG BIOTECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products